[go: up one dir, main page]

FR2839080B1 - Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris - Google Patents

Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris

Info

Publication number
FR2839080B1
FR2839080B1 FR0304170A FR0304170A FR2839080B1 FR 2839080 B1 FR2839080 B1 FR 2839080B1 FR 0304170 A FR0304170 A FR 0304170A FR 0304170 A FR0304170 A FR 0304170A FR 2839080 B1 FR2839080 B1 FR 2839080B1
Authority
FR
France
Prior art keywords
mute
protein
expression
preparing
product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0304170A
Other languages
English (en)
Other versions
FR2839080A1 (fr
Inventor
Alex Bollen
Arsene Burny
Sophie Hallez
Alain Jacquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Neovacs SA
Original Assignee
Neovacs SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0304170A priority Critical patent/FR2839080B1/fr
Application filed by Neovacs SA filed Critical Neovacs SA
Priority to PCT/BE2003/000073 priority patent/WO2003090664A2/fr
Priority to US10/512,190 priority patent/US20060099219A1/en
Priority to CA002483468A priority patent/CA2483468A1/fr
Priority to EP03717062A priority patent/EP1515987A2/fr
Priority to BR0309603-3A priority patent/BR0309603A/pt
Priority to AU2003221650A priority patent/AU2003221650A1/en
Publication of FR2839080A1 publication Critical patent/FR2839080A1/fr
Application granted granted Critical
Publication of FR2839080B1 publication Critical patent/FR2839080B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR0304170A 2002-04-24 2003-04-03 Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris Expired - Fee Related FR2839080B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0304170A FR2839080B1 (fr) 2003-04-03 2003-04-03 Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris
US10/512,190 US20060099219A1 (en) 2002-04-24 2003-04-24 Mutated hpv-16e7 polypeptide, pharmaceutical composition comprising it and its preparation process
CA002483468A CA2483468A1 (fr) 2002-04-24 2003-04-24 Polypeptide hpv-16 e7 mute, preparations pharmaceutiques le contenant, et son procede de preparation
EP03717062A EP1515987A2 (fr) 2002-04-24 2003-04-24 Polypeptide hpv-16 e7 mute, preparations pharmaceutiques le contenant, et son procede de preparation
PCT/BE2003/000073 WO2003090664A2 (fr) 2002-04-24 2003-04-24 Polypeptide hpv-16 e7 mute, preparations pharmaceutiques le contenant, et son procede de preparation
BR0309603-3A BR0309603A (pt) 2002-04-24 2003-04-24 Polipeptìdeo e7 mutado de hpv-16, composição farmacêutica que o compreende e seu processo de preparação
AU2003221650A AU2003221650A1 (en) 2002-04-24 2003-04-24 Mutated hpv-16 e7 polypeptide, pharmaceutical composition comprising it and its preparation process

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0304170A FR2839080B1 (fr) 2003-04-03 2003-04-03 Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris

Publications (2)

Publication Number Publication Date
FR2839080A1 FR2839080A1 (fr) 2003-10-31
FR2839080B1 true FR2839080B1 (fr) 2007-09-28

Family

ID=28800145

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0304170A Expired - Fee Related FR2839080B1 (fr) 2002-04-24 2003-04-03 Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris

Country Status (1)

Country Link
FR (1) FR2839080B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2038581A1 (fr) * 1990-03-20 1991-09-21 Martin Muller Determinants antigeniques sereux des proteines 16 du virus des papillomes humains (vph)
GB9717953D0 (en) * 1997-08-22 1997-10-29 Smithkline Beecham Biolog Vaccine

Also Published As

Publication number Publication date
FR2839080A1 (fr) 2003-10-31

Similar Documents

Publication Publication Date Title
WO2002055519A3 (fr) Nouveau procede pour la synthese de phenylamide d'acide de 5-(4-fluorophenyl)-1-[2-((2r, 4r)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylique
TW200740779A (en) Intermediate compound for synthesizing pharmaceutical agent and production method thereof
ATE333509T1 (de) Methoden und materialien zur synthese von organischen produkten
PL392726A1 (pl) Nowe związki pośrednie do syntezy związków triazolopirymidyny oraz sposób ich wytwarzania
EP1848791A4 (fr) Procedes de production de produit de fermentation
FR2889526B1 (fr) 7-aza-indazoles substitues, compositions les contenant, procede de fabrication et utilisation
FR2804971B1 (fr) Adn codant une acetohydroxyacide synthase, bacterie le contenant et procede de production de l-valine par culture de cette bacterie
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
ATE417121T1 (de) Verfahren zur kollagenextraktion das mikrobielle fermentierung umfasst
TW200613239A (en) Process for producing optically active amine derivatives
ATE515566T1 (de) Skalierbares fermentationsverfahren
EP1357176A4 (fr) Procede de production de boisson au malt fermentee
MX2010003826A (es) Preparacion de dihidrotieno [3,2-d] pirimidinas e intermedios usados en la misma.
TW200519066A (en) Preparation of ethylenamines
AU2003272072A1 (en) A process to prepare pioglitazone via several intermediates.
FR2846974B1 (fr) Procede de production d'une substance cible par fermentation
ATE440816T1 (de) Neues verfahren zur synthese substituierter alpha-aminoindanderivate
FR2839080B1 (fr) Procede de preparation d'un produit d'expression d'un adn codant une proteine e7 mutee de hpv-16, par des cellules de la levure pichia pastoris
WO2010064262A3 (fr) Procédé pour la production de mélanine hydrosoluble utilisant une souche du champignon gliocephalotrichum
EP1716243A4 (fr) Procede de production a grande echelle d'adn plasmidique par fermentation de e. coli
DE602005022099D1 (de) Fluorisierungsverfahren zur synthese von 2-ä18fü fluoro-2-deoxy-d-glukose
EP1382674A3 (fr) Réductase de l'acide alpha-keto, méthode pour sa production et méthode pour la production d'acides alpha-hydroxy optiquement actifs qui utilise ladite réductase
WO2007011910A3 (fr) Addition asymetrique catalysee par une amine chirale de nucleophiles carbones sur des imines
Watanabe et al. Double β-alanine substitutions incorporated in 12-ring pyrrole-imidazole polyamides for lengthened DNA minor groove recognition
EP1711603A4 (fr) Saccharomyces cerevisiae transformee et procede de production en masse de proteine lk8 l'utilisant

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20141231